Should you wean off Wegovy before stopping?

What your body does when semaglutide leaves the system

Semaglutide has a half-life of roughly one week, meaning a meaningful amount is still active seven days after your last dose and mostly cleared by around five weeks. During that clearance window, the appetite-suppressing effect fades, GLP-1 receptors in the gut and brain receive less stimulation, gastric emptying returns to its usual pace, and hunger hormones begin to reassert themselves.

This is not withdrawal in any clinical sense. There is no physical dependence on semaglutide, and you will not experience the kind of rebound that follows stopping certain other medicines. What you may notice is that food feels less filling, cravings re-emerge faster than expected, and portion sizes that felt comfortable on treatment no longer satisfy. For many people, that shift is gradual over a few weeks; for others, hunger rebounds more sharply.

Clinical trial follow-up data (including observations from the STEP programme) show that a substantial portion of weight lost on semaglutide can return within a year of stopping, particularly without ongoing lifestyle support. If you are still forming a view on whether this treatment is right for you, it is worth reading through our guidance on whether you should take Wegovy, rather than simply stopping the next pen.

Does tapering the dose actually help?

A question our prescribers hear most weeks is whether stepping back down through the dose schedule before stopping (say, moving from 2.4 mg back to 1.7 mg, then to 1.0 mg) gives a gentler landing. The honest answer is that good quality evidence specifically comparing tapering versus abrupt cessation of semaglutide in people using it for weight management is limited, and our page on whether you have to wean off Wegovy explores that question in more detail. The NHS guidance on semaglutide does not give a formal tapering protocol for weight-loss use.

In practice, some prescribers do recommend a gradual step-down for patients who have been on higher doses for a long time, on the basis that it slows the pace at which hunger returns and gives behavioural habits time to carry more of the load. Others find that, given semaglutide's long half-life, the pharmacological difference between a two-step taper and stopping outright is modest, and that the energy is better spent reinforcing diet and activity patterns.

If you are curious whether a gradual approach is right for your situation, our guidance on how to wean off Wegovy safely is worth exploring before you make a decision. Your prescriber's view on your specific dose history and health picture matters far more than any general rule.

When stopping sooner makes sense, and when it does not

There are legitimate reasons to stop Wegovy before reaching a long-term maintenance phase: a planned pregnancy (the medicine is not recommended during pregnancy, breastfeeding, or when actively trying to conceive), a surgical procedure requiring anaesthesia, a new health condition, or simply a decision that treatment is complete. In each case the timing and method of stopping should be discussed with your prescriber rather than decided unilaterally.

What is less advisable is stopping purely because of a week of nausea, a short stretch of slow progress, or a misunderstanding about how the dose schedule works. The early titration phase of Wegovy (starting low and increasing gradually) is specifically designed to manage side effects; many people who stop in the first few months have not yet reached a dose at which the full clinical effect is established. If that sounds like your situation, it may be worth reading about the factors that help determine whether Wegovy is suitable for you before concluding that stopping is the answer.

Cost is another practical factor. If treatment cost is the driver, it is worth understanding what a transparent private prescription covers before stopping, the options for where to obtain Wegovy in the UK can help frame that comparison honestly. As NICE has noted in its assessment of semaglutide (see NICE TA875), treatment is intended to be used alongside sustained lifestyle changes; stopping without those habits in place tends to produce faster regain regardless of how the medicine is discontinued.

Planning the conversation with your prescriber

The most practical thing you can do before stopping Wegovy, whatever your reason, is to have an explicit conversation with whoever holds your prescription. A good stopping plan covers: the pace of dose reduction (if any), what to expect in terms of appetite change over the first four to eight weeks, which lifestyle supports to reinforce before the medicine clears, and a clear weight-monitoring interval so that significant regain is caught early rather than after many months.

At nume, no repeat order is dispatched without a clinical review of your current status. That process exists precisely so that decisions like pausing, stepping down a dose, or stopping entirely are made with a prescriber who knows your history, not in a vacuum. If you are weighing up whether to start, continue, or stop, our page covering whether Wegovy is the right choice for your circumstances can help you prepare for that conversation, and our clinical team (including our lead prescriber) is available to discuss your specific situation.

Starting or restarting any prescription treatment follows the same route: a free consultation, same-day clinical review by a GPhC-registered prescriber, and a clear recommendation based on your health picture. If you would like that conversation, you can start your free consultation with our prescribing team today.